Blockade of TNFα may modify the incidence of MI and influence the severity and mortality post MI via postinfarct remodelling.17, 18 This relationship has not previously been explored because the relevant data are generally not collected within drug registries. The gene discussed is TNF; the disease is myocardial infarction.